You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

RET-PTC1

Showing 1 - 25 of 785
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

RET-altered Non Small Cell Lung Cancer, Medullary Thyroid Cancer, RET-altered Papillary Thyroid Cancer Trial in Worldwide

Active, not recruiting
  • RET-altered Non Small Cell Lung Cancer
  • +39 more
  • pralsetinib (BLU-667)
  • Phoenix, Arizona
  • +65 more
Nov 10, 2022

RET-altered Solid Tumors Trial in Shanghai (APS03118)

Recruiting
  • RET-altered Solid Tumors
  • Shanghai, Shanghai, China
    Shanghai Chest Hospital
Dec 8, 2022

Chemotherapy or Chemotherapy Plus PD-1 Antibody in RET Fusion

Recruiting
  • Non-small Cell Lung Cancer
    • Changsha, Hunan, China
      Yongchang Zhang
    Mar 1, 2022

    NSCLC, Medullary Thyroid Cancer, Colon Cancer Trial in Worldwide (LOXO-292)

    Recruiting
    • Non-Small Cell Lung Cancer
    • +3 more
    • Scottsdale, Arizona
    • +84 more
    Oct 10, 2022

    ALK-positive NSCLC (NSCLC), RET-positive NSCLC (NSCLC), RET-positive Thyroid Cancer Trial in Irvine, Boston (Alectinib)

    Terminated
    Has Results
    • ALK-positive Non-small Cell Lung Cancer (NSCLC)
    • +2 more
    • Irvine, California
    • +3 more
    Aug 30, 2021

    Non Small Cell Lung Cancer, Medullary Thyroid Cancer, RET Gene Mutation Trial in Korea, Republic of, United States (TPX-0046)

    Recruiting
    • Non Small Cell Lung Cancer
    • +4 more
    • Irvine, California
    • +15 more
    Mar 9, 2022

    Lung Cancer, Non Small Cell Lung Cancer Trial in Aurora (Amivantamab 1050mg, Amivantamab 1400mg, Amivantamab (to be determined))

    Not yet recruiting
    • Lung Cancer
    • Non Small Cell Lung Cancer
    • Amivantamab 1050mg
    • +2 more
    • Aurora, Colorado
    • +2 more
    Apr 25, 2023

    Advanced Nonhaematologic Malignancies Trial in Worldwide (BOS172738)

    Active, not recruiting
    • Advanced Nonhaematologic Malignancies
    • Philadelphia, Pennsylvania
    • +20 more
    Sep 23, 2022

    Advanced Solid Tumor Trial (HEC169096)

    Not yet recruiting
    • Advanced Solid Tumor
    • (no location specified)
    Jul 6, 2022

    Ovarian Cancer Trial in Oklahoma City (Unesbulin)

    Active, not recruiting
    • Ovarian Cancer
    • Oklahoma City, Oklahoma
      University of Oklahoma Health Sciences Center
    Feb 21, 2022

    Huntington Disease Trial in Worldwide (PTC518, Placebo)

    Recruiting
    • Huntington Disease
    • Birmingham, Alabama
    • +18 more
    Nov 9, 2022

    Advanced Malignant Tumor, Metastatic Malignant Tumor, Recurrent Malignant Tumor Trial in Houston (Everolimus, Laboratory

    Recruiting
    • Advanced Malignant Neoplasm
    • +3 more
    • Houston, Texas
      M D Anderson Cancer Center
    Dec 9, 2022

    Leukemia, Myeloid, Acute, AML Trial in United States (PTC299)

    Terminated
    • Leukemia, Myeloid, Acute
    • AML
    • Aurora, Colorado
    • +16 more
    Jan 18, 2022

    Laparoscopic Colorectal Surgeries Trial in Montréal-Est (Rocuronium IV bolus 0.1 mg/kg guided by TOF that must remain between

    Recruiting
    • Laparoscopic Colorectal Surgeries
    • Rocuronium IV bolus 0.1 mg/kg guided by TOF that must remain between 1-3 during surgery
    • Rocuronium IV bolus 0.1 mg/kg guided by TOF 0/4 and PTC≤ 2
    • Montréal-Est, Quebec, Canada
      Hopital Maisonneuve Rosemont, CIUSSS de l'Est de l'Ile de Montré
    Apr 4, 2022

    Nonsmall Cell Lung Cancer Trial in Shanghai (HS-10365 capsules)

    Recruiting
    • Nonsmall Cell Lung Cancer
    • HS-10365 capsules
    • Shanghai, Shanghai, China
      Shanghai Chest Hospital
    Nov 22, 2023

    RET-altered Non Small Cell Lung Cancer, Medullary Thyroid Cancer, RET-altered Papillary Thyroid Cancer Trial in Chang chun

    Not yet recruiting
    • RET-altered Non Small Cell Lung Cancer
    • +3 more
    • Chang chun, Jilin, China
      Jinlin Province Cancer Hosipital
    Dec 21, 2022

    NSCLC Trial in Shanghai (SY-5007)

    Recruiting
    • Non-Small Cell Lung Cancer
    • Shanghai, Shanghai, China
      Shanghai Pulmonary Hospital
    Sep 4, 2023

    Phenylketonuria Trial in Worldwide (PTC923, Placebo)

    Recruiting
    • Phenylketonuria
    • Stanford, California
    • +42 more
    Nov 23, 2022

    Advanced Solid Tumor Trial in Los Angeles (EP0031)

    Recruiting
    • Advanced Solid Tumor
    • Los Angeles, California
    • +3 more
    Dec 1, 2022

    Breast Cancer, HER2 Positive Trial in Netherlands (PTC+Pertuzumab, FEC-T+Pertuzumab)

    Active, not recruiting
    • Breast Cancer
    • HER2 Positive
    • Alkmaar, Netherlands
    • +32 more
    Oct 11, 2022

    MDD Trial in Ames (Resistance Exercise Training)

    Active, not recruiting
    • Major Depressive Disorder
    • Resistance Exercise Training
    • Ames, Iowa
      Iowa State University
    Jan 12, 2023

    Phenylketonuria Trial in Worldwide (PTC923)

    Recruiting
    • Phenylketonuria
    • Stanford, California
    • +42 more
    Jun 23, 2022

    NSCLC, Medullary Thyroid Cancer, Solid Tumor Trial in Shanghai, Tianjin (SY-5007)

    Recruiting
    • Non-Small Cell Lung Cancer
    • +2 more
    • Shanghai, Shanghai, China
    • +1 more
    Mar 17, 2022

    Solid Tumor, Medullary Thyroid Cancer Trial in China (Selpercatinib)

    Active, not recruiting
    Has Results
    • Solid Tumor
    • Medullary Thyroid Cancer
    • Guangzhou, Guangdong, China
    • +12 more
    May 9, 2022

    Medullary Thyroid Cancer Trial in Worldwide (Selpercatinib, Cabozantinib, Vandetanib)

    Recruiting
    • Medullary Thyroid Cancer
    • Birmingham, Alabama
    • +148 more
    Jan 18, 2023